The laboratory diagnosis of Pseudomonas aeruginosa that produce metallo-β-lactamases in a Dutch tertiary care centre

Scandinavian Journal of Infectious Diseases

Volumn 43, Issue 8, 2011, Pages 596-602

  Van Der Bij, Akke K ^a   Mol, Marco ^a   Van Westreenen, Mireille ^a   Goessens, Wil H F ^a   Pitout, Johann D D ^b,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CALGARY LABORATORY SERVICES   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Disk test; Laboratory detection; Metallo lactamases; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; CEFTAZIDIME; CIPROFLOXACIN; DORIPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; TOBRAMYCIN;

ACCURACY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISK DIFFUSION; ENZYME ASSAY; LABORATORY DIAGNOSIS; MICROBIAL SENSITIVITY TEST; NONHUMAN; PSEUDOMONAS AERUGINOSA; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TERTIARY HEALTH CARE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARBAPENEMS; DISK DIFFUSION ANTIMICROBIAL TESTS; EDETIC ACID; HUMANS; IMIPENEM; LABORATORIES; MICROBIAL SENSITIVITY TESTS; NETHERLANDS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REPRODUCIBILITY OF RESULTS; THIENAMYCINS;

EID: 79960443393     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2011.574148     Document Type: Article

References (29)

1. Turner PJ. MYSTIC Europe 2007: activity of meropenem and other broad-spectrum agents against nosocomial isolates. Diagn Microbiol Infect Dis 2009;63:217-22
2. Souli M, Galani I, Giamarellou H. Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill 2008;13. pii: 19045
3. Rhomberg PR, Jones RN. Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008). Diagn Microbiol Infect Dis 2009;65:414-26
4. Wang H, Chen M, Ni Y, Liu Y, Sun H, Yu Y, et al. Antimicrobial resistance among clinical isolates from the Chinese Meropenem Surveillance Study (CMSS), 2003-2008. Int J Antimicrob Agents 2010;35:227-34
5. Fujimura T, Anan N, Sugimori G, Watanabe T, Jinushi Y, Yoshida I, et al. Susceptibility of Pseudomonas aeruginosa clinical isolates in Japan to doripenem and other antipseudomonal agents. Int J Antimicrob Agents 2009;34:523-8
6. Livermore DM. Of Pseudomonas, porins, pumps and carbapenems. J Antimicrob Chemother 2001;47:247-50 (Pubitemid 32229565)
7. Walsh TR. Clinically signifi cant carbapenemases: an update. Curr Opin Infect Dis 2008;21:367-71
8. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallobeta- lactamases: the quiet before the storm? Clin Microbiol Rev 2005;18:306-25
9. Gupta V. Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species. Expert Opin Investig Drugs 2008;17:131-43 (Pubitemid 351578196)
10. Rossolini GM, Mantengoli E. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect 2005;11(Suppl):17-32 (Pubitemid 40946169)
11. Laupland KB, Parkins MD, Church DL, Gregson DB, Louie TJ, Conly JM, et al. Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallo-beta-lactamase (MBL)-producing strains. J Infect Dis 2005;192:1606-12 (Pubitemid 41504696)
12. Zavascki AP, Barth AL, Gonçalves AL, Moro AL, Fernandes JF, Martins AF, et al. The infl uence of metallo- β -lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections. J Antimicrob Chemother 2006;58:387-92 (Pubitemid 44294952)
13. Pena C, Suarez C, Tubau F, Gutierrez O, Domínguez A, Oliver A, et al. Nosocomial spread of Pseudomonas aeruginosa producing the metallo-beta-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications. Clin Microbiol Infect 2007;13:1026-9 (Pubitemid 47382261)
14. Pitout JD, Gregson DB, Poirel L, McClure JA, Le P, Church DL. Detection of Pseudomonas aeruginosa producing metallo-beta-lactamases in a large centralized laboratory. J Clin Microbiol 2005;43:3129-35 (Pubitemid 40981312)
15. Picao RC, Andrade SS, Nicoletti AG, Campana EH, Moraes GC, Mendes RE, et al. Metallo-beta-lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIMproducing isolates. J Clin Microbiol 2008;46:2028-37 (Pubitemid 351831838)
16. Masuda G, Tomioka S, Hasegawa M. Detection of betalactamase production by Gram-negative bacteria. J Antibiot (Tokyo) 1976;29:662-4
17. Smith Moland E, Hanson ND, Herrera VL, Black JA, Lockhart TJ, Hossain A, et al. Plasmid-mediated, carbapenem- hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J Antimicrob Chemother 2003;51:711-4
18. Woodford N. Rapid characterization of beta-lactamases by multiplex PCR. Methods Mol Biol 2010;642:181-92
19. Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem-EDTA disk method for differentiation of metallobeta- lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2002;40:3798-801
20. Lee K, Lim YS, Yong D, Yum JH, Chong Y. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2003;41:4623-9 (Pubitemid 37259767)
21. Oh EJ, Lee S, Park YJ, Park JJ, Park K, Kim SI, et al. Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii in a Korean university hospital and comparison of screening methods for detecting metallo-beta-lactamase. J Microbiol Methods 2003; 54:411-8 (Pubitemid 36773983)
22. Walsh TR, Bolmstrom A, Qwarnstrom A, Gales A. Evaluation of a new Etest for detecting metallo-beta-lactamases in routine clinical testing. J Clin Microbiol 2002;40:2755-9 (Pubitemid 35284937)
23. Berges L, Rodriguez-Villalobos H, Deplano A, Struelens MJ. Prospective evaluation of imipenem/EDTA combined disc and Etest for detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa. J Antimicrob Chemother 2007;59:812-3 (Pubitemid 47073432)
24. Ratkai C, Quinteira S, Grosso F, Monteiro N, Nagy E, Peixe L. Controlling for false positives: interpreting MBL Etest and MBL combined disc test for the detection of metallobeta- lactamases. J Antimicrob Chemother 2009;64:657-8
25. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 18th informational supplement M100-S18. Wayne, PA: CLSI; 2008
26. Pitout JD, Le PG, Moore KL, Church DL, Gregson DB. Detection of AmpC beta-lactamases in Escherichia coli, Klebsiella spp., Salmonella spp. and Proteus mirabilis in a regional clinical microbiology laboratory. Clin Microbiol Infect 2010;16:165-70
27. Song W, Jeong SH, Kim JS, Kim HS, Shin DH, Roh KH, et al. Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis. Diagn Microbiol Infect Dis 2007;57:315-8 (Pubitemid 46330652)
28. Jacoby GA, Walsh KE, Walker VJ. Identifi cation of extendedspectrum, AmpC, and carbapenem-hydrolyzing betalactamases in Escherichia coli and Klebsiella pneumoniae by disk tests. J Clin Microbiol 2006;44:1971-6 (Pubitemid 43902141)
29. Coudron PE. Inhibitor-based methods for detection of plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis. J Clin Microbiol 2005;43:4163-7 (Pubitemid 41129715)